Osteoporosis International

, Volume 24, Issue 11, pp 2763–2764

Standardising the descriptive epidemiology of osteoporosis: recommendations from the Epidemiology and Quality of Life Working Group of IOF

  • J. A. Kanis
  • J. D. Adachi
  • C. Cooper
  • P. Clark
  • S. R. Cummings
  • M. Diaz-Curiel
  • N. Harvey
  • M. Hiligsmann
  • A. Papaioannou
  • D. D. Pierroz
  • S. L. Silverman
  • P. Szulc
  • The Epidemiology and Quality of Life Working Group of IOF
Position Paper

DOI: 10.1007/s00198-013-2413-7

Cite this article as:
Kanis, J.A., Adachi, J.D., Cooper, C. et al. Osteoporos Int (2013) 24: 2763. doi:10.1007/s00198-013-2413-7

Abstract

Summary

The Committee of Scientific Advisors of International Osteoporosis Foundation (IOF) recommends that papers describing the descriptive epidemiology of osteoporosis using bone mineral density (BMD) at the femoral neck include T-scores derived from an international reference standard.

Introduction

The prevalence of osteoporosis as defined by the T-score is inconsistently reported in the literature which makes comparisons between studies problematic.

Methods

The Epidemiology and Quality of Life Working Group of IOF convened to make its recommendations and endorsement sought thereafter from the Committee of Scientific Advisors of IOF.

Results

The Committee of Scientific Advisors of IOF recommends that papers describing the descriptive epidemiology of osteoporosis using BMD at the femoral neck include T-scores derived from the National Health and Nutrition Examination Survey III reference database for femoral neck measurements in Caucasian women aged 20–29 years.

Conclusions

It is expected that the use of the reference standard will help resolve difficulties in the comparison of results between studies and the comparative assessment of new technologies.

Keywords

BMDDescriptive epidemiologyFemoral neckOsteoporosis

Copyright information

© International Osteoporosis Foundation and National Osteoporosis Foundation 2013

Authors and Affiliations

  • J. A. Kanis
    • 1
  • J. D. Adachi
    • 2
  • C. Cooper
    • 3
    • 4
  • P. Clark
    • 5
  • S. R. Cummings
    • 6
  • M. Diaz-Curiel
    • 7
  • N. Harvey
    • 3
  • M. Hiligsmann
    • 8
  • A. Papaioannou
    • 9
  • D. D. Pierroz
    • 10
  • S. L. Silverman
    • 11
  • P. Szulc
    • 12
  • The Epidemiology and Quality of Life Working Group of IOF
  1. 1.WHO Collaborating Centre for Metabolic Bone DiseasesUniversity of Sheffield Medical SchoolSheffieldUK
  2. 2.Division of Rheumatology, Department of MedicineMcMaster UniversityHamiltonCanada
  3. 3.MRC Lifecourse Epidemiology UnitUniversity of SouthamptonSouthamptonUK
  4. 4.NIHR Musculoskeletal Biomedical Research UnitUniversity of OxfordOxfordUK
  5. 5.Clinical Epidemiology Unit, Hospital Infantil de México “Federico Gómez”Facultad de Medicina UNAMMexico CityMexico
  6. 6.San Fransisco Coordinating CenterCalifornia Pacific Medical Center Research InstituteSan FransiscoUSA
  7. 7.Servicio de Medicina InternaFundacion Jimenez DiazMadridSpain
  8. 8.Department of Health Services Research, School for Public Health and Primary Care (CAPHRI)Maastricht UniversityMaastrichtThe Netherlands
  9. 9.Department of MedicineMcMaster UniversityHamiltonCanada
  10. 10.International Osteoporosis FoundationNyonSwitzerland
  11. 11.OMC Clinical Research CenterBeverly HillsUSA
  12. 12.INSERM UMR 1033University of LyonLyonFrance